We are conducting a new research study to help regulate blood sugar in adults who may be at increased risk of type 2 diabetes. Participants must be age 18-59 years. Participants cannot have diabetes, cardiovascular disease or be pregnant/nursing.

The study involves

• Several visits to the Samaritan Athletic Medicine Center in Corvallis over approximately 4-5 months.

The study includes

• Metabolic testing (including blood and muscle sampling)
• Taking 1 pill per day for 13 weeks
• Consultation with a physician

This study is called Use of empagliflozin to treat prediabetes: a randomized, placebo-controlled, 13-week intervention trial. It is being conducted by Sean Newsom, Ph.D., and Matthew Robinson, Ph.D., Oregon State University and Samaritan Health Services.

To determine if you are eligible to participate in this study, please complete the following online survey:

   Eligibility Survey

If you are interested in learning more about this opportunity, please contact us at [email protected].